Literature DB >> 890553

The effects of various diphosphonates on a rat model of cardiac calciphylaxis.

I Y Rosenblum, H E Black, J F Ferrell.   

Abstract

Seven diphosphonate analogs were treated for their effects on myocardial and cardiovascular degeneration and calcification in an experimental model of cardiac calciphylaxis. A single oral dose of dihydrotachysterol (DHT) administered to rats induced myocardial and vascular degeneration, focal myocarditis and vasculitis, and myocardial and vascular mineralization. The results demonstrated a considerable variation among the various diphosphonates in their ability to block the pathological changes observed in this model. Ethane-1-hydroxy-1,1-diphosphonate (EHDP) was the most effective diphosphonate in reducing myocardial and vascular degeneration and calcification, whereas diphosphonates such as ethane-1-amino-1,1-diphosphonate (EADP) and hydroxymethylene diphosphonate (HMDP) had little or no effect compared to saline controls. For those diphosphonates which were effective, e.g., EHDP, the tissue-protective effects were observed whether the rats were treated with drug prior to the administration of DHT, or whether drug treatment commenced after DHT administration. The results are discussed in terms of the known biological properties of the diphosphonate drugs.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 890553     DOI: 10.1007/bf02012781

Source DB:  PubMed          Journal:  Calcif Tissue Res        ISSN: 0008-0594


  23 in total

1.  AN ELECTRON MICROSCOPIC STUDY OF CARDIAC NECROSIS PRODUCED BY 9 ALPHA-FLUOROCORTISOL AND SODIUM PHOSPHATE.

Authors:  A N D AGOSTINO
Journal:  Am J Pathol       Date:  1964-10       Impact factor: 4.307

2.  The inhibitory effect of phosphonates on the formation of calcium phosphate crystals in vitro and on aortic and kidney calcification in vivo.

Authors:  H A Fleisch; R G Russell; S Bisaz; R C Mühlbauer; D A Williams
Journal:  Eur J Clin Invest       Date:  1970-03       Impact factor: 4.686

Review 3.  Diphosphonates. Experimental and clinical aspects.

Authors:  R G Russell; R Smith
Journal:  J Bone Joint Surg Br       Date:  1973-02

4.  Diphosphonate treatment of calcinosis universalis.

Authors:  R L Cram; R Barmada; W B Geho; R D Ray
Journal:  N Engl J Med       Date:  1971-10-28       Impact factor: 91.245

5.  Effect of disodium ethane-1-hydroxy-1, 1-diphosphonate on bone formation.

Authors:  W R King; M D Francis; W R Michael
Journal:  Clin Orthop Relat Res       Date:  1971       Impact factor: 4.176

6.  Morphologic changes in cardiac and skeletal muscle induced by corticosteroids.

Authors:  A N D'Agostino; M Chiga
Journal:  Ann N Y Acad Sci       Date:  1966-09-09       Impact factor: 5.691

7.  Editorial: Diphosphonate treatment in bone disease.

Authors:  H Fleisch; J P Bonjour
Journal:  N Engl J Med       Date:  1973-12-27       Impact factor: 91.245

8.  The effect of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on a rabbit model of athero-arteriosclerosis.

Authors:  I Y Rosenblum; L Flora; R Eisenstein
Journal:  Atherosclerosis       Date:  1975 Nov-Dec       Impact factor: 5.162

9.  Ethane-1-hydroxy-1, 1-diphosphonate (EHDP). Effects on growth and modeling of the rat tibia.

Authors:  S C Miller; W S Jee
Journal:  Calcif Tissue Res       Date:  1975-09-05

10.  Metabolism of disodium ethane-1-hydroxy-1,1-diphosphonate (disodium etidronate) in the rat, rabbit, dog and monkey.

Authors:  W R Michael; W R King; J M Wakim
Journal:  Toxicol Appl Pharmacol       Date:  1972-04       Impact factor: 4.219

View more
  4 in total

Review 1.  Clinical imaging of vascular disease in chronic kidney disease.

Authors:  Alan A Sag; Adrian Covic; Gerard London; Marc Vervloet; David Goldsmith; Jose Luis Gorriz; Mehmet Kanbay
Journal:  Int Urol Nephrol       Date:  2016-02-22       Impact factor: 2.370

2.  Effect of diphosphonates on hydroxyapatite formation induced by calcium-phospholipid-phosphate complexes.

Authors:  A L Boskey; M R Goldberg; A S Posner
Journal:  Calcif Tissue Int       Date:  1979-03-13       Impact factor: 4.333

3.  Suppression of experimental atherosclerosis by the Ca++-antagonist lanthanum. Possible role of calcium in atherogenesis.

Authors:  D M Kramsch; A J Aspen; C S Apstein
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

Review 4.  Drugs in development: bisphosphonates and metalloproteinase inhibitors.

Authors:  Jon B Catterall; Tim E Cawston
Journal:  Arthritis Res Ther       Date:  2002-11-08       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.